NCT03769454View on ClinicalTrials.gov

A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

September 15, 2021

Study Completion Date

March 15, 2022

Conditions
KeratoconjunctivitisOcular Surface Disease
Interventions
DRUG

PP-001

PP-001 eye drops

OTHER

Placebo

Placebo eye drops

Trial Locations (1)

Unknown

University Hospital Vienna, Vienna

Sponsors
All Listed Sponsors
lead

Panoptes Pharma GmbH

INDUSTRY